3D Tissue Models

Drug Design: Vanderbilt University

Total Score People Score Events Score
32 31 10
Date Event Presentation Speakers
April 3, 2011 Evolving Approaches to Early Stage Drug Discovery (Z2) Partnering with Big Pharma to Develop mGluR Allosteric Modulators for CNS Disorders: From HTS to Clinical Candidates P. Jeffrey Conn
Allosteric Modulation of Muscarinic Receptors for Treatment of Schizophrenia and Alzheimer's Disease Prof. Craig Lindsley
Phospholipase D: Discovery and Development of Isoform Selective PLD Inhibitors for the Treatment of Cancer H Alex Brown
July 11, 2010 Translational Cancer Medicine 2010 (USA) Insights into the biology of EGFR T790M-mediated resistance to EGFR TKIs in lung cancer William Pao
February 1, 2010 4th DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCE Track 2: Pre-Clinical to IND Enabling PD Case Study Colleen Niswender
February 8, 2009 CHEMISTRY IN CANCER RESEARCH: A Vital Partnership in Cancer Drug Discovery and Development Keynote Lectures Larry Marnett
Session 9: Chemistry in Support of Cancer Drug Discovery and Development I Richard Caprioli
October 12, 2008 15th North American Regional Meeting - International Society for the Study of Xenobiotics Isoprostane and Isofuran Pathways of Lipid Peroxidation Jack Roberts
The Arachidonate Monooxygenase. An Enzymatic Pathway for the Generation of Physiologically Relevant Oxidized Lipid Mediators Jorge Cadevilla
October 6, 2008 Drug Repositioning Summit Imatinib (Gleevec) for the Treatment of Autoimmune Diseases William H Robinson
May 30, 2008 ASCO Annual'08 Meeting clinical trials-- Conflicts of Interest in Oncology: Understanding the Problems and Finding Solutions (CPO03) Bruce J. Roth
ethics-- Conflicts of Interest in Oncology: Understanding the Problems and Finding Solutions (CPO03) Bruce J. Roth
professional development-- Conflicts of Interest in Oncology: Understanding the Problems and Finding Solutions (CPO03) Bruce J. Roth
clinical problems in oncology-- Conflicts of Interest in Oncology: Understanding the Problems and Finding Solutions (CPO03) Bruce J. Roth
May 18, 2008 G Protein-Coupled Receptors: New Insights in Functional Regulation and Clinical Application (E2) Workshop: Can Industry and Academic Scientists Cooperate to Facilitate Drug Discovery? P. Jeffrey Conn
GPCRs in Preclinical Drug Programs Heidi Hamm
March 16, 2008 Advances in Cancer Research: From the Laboratory to the Clinic SCIENTIFIC SYMPOSIUM 1 TUMOR BIOLOGY Harold L Moses
Regulation of the Tumor Microenvironment Harold L Moses
Inflammation and Cancer: Targets for Prevention and Treatment Raymond N DuBois
December 1, 2007 47TH American Socieity of Cell Biology Cell Matrix Interactions (Room 140A) Alissa Weaver
CLASPs Clutching Microtubule Networks (Room 209 B/C) Irina Kaverina
Recycling Endosomes, A Nexus for Post-Golgi Traffi c (Room 144 B/C) Jim Goldenring
WASP Family Proteins Are Critical Regulators of Actin in the Development of Dendritic Spines and Synapses in Hippocampal A M Wegner, K. M. Meier, Alissa M. Weaver, Devi Majumdar, Donna J Webb
Cholesterol Loading Disrupts the Subcellular Distribution of Prenyl-Polybasic Domain Proteins. LYNNE A LAPIERRE, Jim Goldenring, W B Alford, J Rhayem, Anne K Kenworthy
Cell Migration/Motility Irina Kaverina
Role of Golgi-derived Microtubules in Post-Golgi Traffi cking and Polarized Cell Migration Irina Kaverina
Export of the 60S Ribosomal Subunit Requires Nucleoporin FG-domains That Overlap with both Karyopherin Susan R Wente
Systems Approaches to Understanding Peroxisome Biogenesis J J Smith
Myristoylation of Zebrafi sh Naked Is Required to Antagonize Both Canonical Wnt/β-catenin and Non-canonical Wnt/PCP Signaling. Lilianna Solnica Krezel, Terry Van Raay, Robert J COFFEY
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.